This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

PMS-LOSARTAN-HCTZ

PHARMASCIENCE INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PMS-LOSARTAN-HCTZ in Canada?

Yes. PMS-LOSARTAN-HCTZ 12.5MG 50MG has an active shortage reported to Health Canada (last updated November 1, 2026).

Why is PMS-LOSARTAN-HCTZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PMS-LOSARTAN-HCTZ be available again?

The manufacturer's estimated resolution date is June 21, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength12.5MG 50MG

Report last updated2018-11-30

Checked by MedShort2026-11-12

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02392224

Strength

12.5MG 50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM

Tier

Unrated

Last Updated

2018-11-30

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

PMS-LOSARTAN-HCTZ has 2 shortage/discontinuation reports on file — this is one of them.

2026-11-01

Active Shortage

Disruption of the manufacture of the drug.

Other Products from PHARMASCIENCE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AC&C TABLETS

DIN 02303299

ACET CODEINE 30

DIN 01999648

ACET CODEINE 60

DIN 01999656

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02025337

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02028174

ARTHRITIS PAIN RELIEF

650MG · DIN 02527901